Sensei Biotherapeutics, Inc. (SNSE)
21.60
+0.60
(+2.86%)
USD |
NASDAQ |
May 13, 10:25
Sensei Biotherapeutics Free Cash Flow : -22.40M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| KalVista Pharmaceuticals, Inc. | -- |
| Oncolytics Biotech, Inc. | -19.96M |
| Vir Biotechnology, Inc. | -449.64M |
| Recursion Pharmaceuticals, Inc. | -328.08M |
| Acurx Pharmaceuticals, Inc. | -6.144M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.586M |
| Cash from Investing (Quarterly) | 1.743M |
| Cash from Financing (Quarterly) | -0.152M |
| Free Cash Flow Per Share (Quarterly) | -2.843 |
| Free Cash Flow to Equity (Quarterly) | -3.048M |
| Free Cash Flow to Firm (Quarterly) | -3.58M |
| Free Cash Flow Yield | -14.32% |